• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种经分子成像证实的原位肝外胆管癌新型小鼠模型。

A novel mouse model of orthotopic extrahepatic cholangiocarcinoma confirmed with molecular imaging.

作者信息

Song Xiaodong, Shao Zili, Han Menglin, Liang Huihong

机构信息

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.

Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.

出版信息

Transl Cancer Res. 2019 Apr;8(2):583-591. doi: 10.21037/tcr.2019.03.19.

DOI:10.21037/tcr.2019.03.19
PMID:35116791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8798838/
Abstract

BACKGROUND

Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy in humans. Although early-stage CCA can be managed with surgery, CCA is considered incurable at advanced stages and results in poor quality of life and overall survival. A good orthotopic CCA animal model is essential to perform basic studies investigating CCA in order to understand the molecular pathways that underlie cancer development, and to develop new therapies for the prevention and treatment of CCA. However, to the best of our knowledge, orthotopic extrahepatic CCA animal models have not yet been reported in the literature.

METHODS

In this study, we established an orthotopic extrahepatic CCA model in mice using a two-step surgical procedure.

RESULTS

The characteristics of this model were confirmed using molecular imaging and histological analysis.

CONCLUSIONS

We believe that this CCA animal model, which can be established quickly, easily, and with good reproducibility, will help guide research on novel diagnostic and treatment strategies for extrahepatic CCA.

摘要

背景

胆管癌(CCA)是人类第二常见的原发性肝脏恶性肿瘤。尽管早期CCA可通过手术治疗,但晚期CCA被认为无法治愈,会导致生活质量差和总体生存期缩短。一个良好的原位CCA动物模型对于开展研究CCA的基础研究至关重要,以便了解癌症发生发展的分子途径,并开发预防和治疗CCA的新疗法。然而,据我们所知,文献中尚未报道过原位肝外CCA动物模型。

方法

在本研究中,我们采用两步手术程序在小鼠中建立了原位肝外CCA模型。

结果

使用分子成像和组织学分析证实了该模型的特征。

结论

我们认为,这种能够快速、轻松建立且具有良好重复性的CCA动物模型,将有助于指导肝外CCA新型诊断和治疗策略的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/d847ea29e12e/tcr-08-02-583-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/e06395637c77/tcr-08-02-583-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/1ffe9b727e90/tcr-08-02-583-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/2c9d14525bfa/tcr-08-02-583-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/a1a263be36b0/tcr-08-02-583-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/19c448560ce2/tcr-08-02-583-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/d847ea29e12e/tcr-08-02-583-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/e06395637c77/tcr-08-02-583-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/1ffe9b727e90/tcr-08-02-583-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/2c9d14525bfa/tcr-08-02-583-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/a1a263be36b0/tcr-08-02-583-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/19c448560ce2/tcr-08-02-583-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57d8/8798838/d847ea29e12e/tcr-08-02-583-f6.jpg

相似文献

1
A novel mouse model of orthotopic extrahepatic cholangiocarcinoma confirmed with molecular imaging.一种经分子成像证实的原位肝外胆管癌新型小鼠模型。
Transl Cancer Res. 2019 Apr;8(2):583-591. doi: 10.21037/tcr.2019.03.19.
2
Cancer review: Cholangiocarcinoma.癌症综述:胆管癌。
J Carcinog. 2015 Feb 23;14:1. doi: 10.4103/1477-3163.151940. eCollection 2015.
3
Animal models of cholangiocarcinoma.胆管癌动物模型。
Curr Opin Gastroenterol. 2013 May;29(3):312-8. doi: 10.1097/MOG.0b013e32835d6a3e.
4
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted.FOSL1 通过可作为治疗靶点的转录效应因子促进胆管癌的发生。
J Hepatol. 2021 Aug;75(2):363-376. doi: 10.1016/j.jhep.2021.03.028. Epub 2021 Apr 20.
5
Current Advances in Basic and Translational Research of Cholangiocarcinoma.胆管癌基础与转化研究的当前进展
Cancers (Basel). 2021 Jul 1;13(13):3307. doi: 10.3390/cancers13133307.
6
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.肝内和肝外胆管癌的危险因素:系统评价和荟萃分析。
J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16.
7
FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.FOXF1 作为肝门部胆管癌或转移性胰腺导管腺癌的免疫组化标志物。单机构经验。
Pathol Oncol Res. 2021 Apr 20;27:1609756. doi: 10.3389/pore.2021.1609756. eCollection 2021.
8
Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.从患者来源的异种移植小鼠模型中建立高转移性胆管癌细胞系。
Cells. 2019 May 23;8(5):496. doi: 10.3390/cells8050496.
9
Protein-loss of SWI/SNF-complex core subunits influences prognosis dependent on histological subtypes of intra- and extrahepatic cholangiocarcinoma.SWI/SNF复合体核心亚基的蛋白质丢失对肝内和肝外胆管癌组织学亚型的预后有影响。
Oncol Lett. 2021 May;21(5):349. doi: 10.3892/ol.2021.12610. Epub 2021 Mar 3.
10
Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.泰国肝外胆管癌患者手术治疗后的生存率。
Asian Pac J Cancer Prev. 2013;14(1):321-4. doi: 10.7314/apjcp.2013.14.1.321.

本文引用的文献

1
Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.菠萝蛋白酶和木瓜蛋白酶对人胆管癌细胞系抗肿瘤作用的比较研究
Int J Oncol. 2016 May;48(5):2025-34. doi: 10.3892/ijo.2016.3411. Epub 2016 Mar 1.
2
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.建立具有KRAS突变的患者来源的肝内胆管癌异种移植模型。
BMC Cancer. 2016 Feb 11;16:90. doi: 10.1186/s12885-016-2136-1.
3
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
肝内和肝外胆管癌的评估和管理。
Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22.
4
Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent.以叶酸为靶向剂将5-氟尿嘧啶靶向递送至胆管癌细胞。
Mater Sci Eng C Mater Biol Appl. 2016 Mar;60:411-415. doi: 10.1016/j.msec.2015.11.062. Epub 2015 Nov 24.
5
Cholangiocarcinoma: from molecular biology to treatment.胆管癌:从分子生物学至治疗
Med Oncol. 2015 Nov;32(11):245. doi: 10.1007/s12032-015-0692-x. Epub 2015 Oct 1.
6
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.一种伴有潜在肝硬化的肝细胞癌原位小鼠模型。
Nat Protoc. 2015 Aug;10(8):1264-74. doi: 10.1038/nprot.2015.080. Epub 2015 Jul 23.
7
Profiles of cancer stem cell subpopulations in cholangiocarcinomas.胆管癌中癌症干细胞亚群的特征
Am J Pathol. 2015 Jun;185(6):1724-39. doi: 10.1016/j.ajpath.2015.02.010. Epub 2015 Apr 17.
8
Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma.转化生长因子-β1 诱导的上皮-间充质转化在胆管癌中产生具有干细胞特性的 ALDH 阳性细胞。
Cancer Lett. 2014 Nov 28;354(2):320-8. doi: 10.1016/j.canlet.2014.08.030. Epub 2014 Sep 3.
9
Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.Gankyrin 通过激活人胆管癌细胞中的 IL-6/STAT3 信号通路促进肿瘤生长和转移。
Hepatology. 2014 Mar;59(3):935-46. doi: 10.1002/hep.26705. Epub 2014 Jan 29.
10
Animal models of cholangiocarcinoma.胆管癌动物模型。
Curr Opin Gastroenterol. 2013 May;29(3):312-8. doi: 10.1097/MOG.0b013e32835d6a3e.